feed info
6 articles from ScienceNOW
Supply of monkeys for research is at a crisis point, U.S. government report concludes
The supply of monkeys for research is shrinking, and access to remaining animals is becoming increasingly unreliable. That’s the
dire message
of a U.S. National Academies of Sciences, Engineering, and Medicine report released today, which concludes that the situation is compromising critical biomedical research now—and will continue to do so well into the future....
‘Lost’ microbial genes found in dental plaque of ancient humans
About 19,000 years ago, a woman died in northern Spain. Her body was deliberately buried with pieces of the natural pigment ochre and placed behind a block of limestone in a cave known as El Mirón. When her ochre-dyed bones were unearthed in 2010, archaeologists dubbed her the Red Lady. The careful treatment of her body provided scientists with insights into how people from the time...
News at a glance: U.S. tallies old-growth forests, Canadian scientists march for higher pay, and condor poop reveals the birds’ ancient history
FOREST ECOLOGY
U.S. boosts tally of old forests
Last year, President Joe Biden surprised forest scientists when he ordered an inventory of the government’s holdings of mature and old-growth forests by this Earth Day. It triggered a scramble by the U.S. Forest Service and Bureau of Land Management to create a formal definition of what...
A farewell to the particle accelerator that was my father’s baby
As the rebuild of the Advanced Photon Source commences, a look at the craft of building giant scientific machines
Twist of fate: What happens when a top Parkinson’s researcher gets the disease
Though therapies may come too late for him, Tim Greenamyre sees hope on the horizon for patients
‘It’s not a miracle drug’: Eli Lilly’s antibody slows Alzheimer’s disease but safety issues linger
Clinical trial results released today by Eli Lilly and Co. indicate its antibody donanemab
clearly, if perhaps modestly, slows the progression of Alzheimer’s disease
. Following on the heels of comparable results for a similar antibody, lecanemab, the data bolster the long-held but contested hypothesis that preventing the accumulation of a protein called beta amyloid in...